[ad_1] A closely watched clinical trial of a potential Alzheimer’s drug failed to prevent or slow cognitive decline; this was another disappointment in the long and arduous efforts to findRead More
Tag: Alzheimers
Scientists Question the Data Behind an Experimental Alzheimer’s Drug
[ad_1] “There is no possibility, no logical way for this to happen,” he said. Elisabeth Bik, a leading expert In image manipulation, short sellers became aware of the company lastRead More
In a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug
[ad_1] In the interview, Mr. Johns repeated these statements. When asked if association officials have contacted Biogen since Medicare’s recommendation, he said, “I think some of our friends had aRead More
Medicare Recommends Sharply Limiting Alzheimer’s Drug Coverage
[ad_1] Medicare’s coverage decision is considered crucial to the future of Aduhelm, which is priced at $28,200 per patient per year. About 80 percent of patients eligible for medication areRead More
House Committees Request FDA Registrations for Alzheimer’s Drug Approval
[ad_1] Two strong congressional committees investigating the controversial federal approval of Biogen’s Alzheimer’s drug Aduhelm requested extensive information and documentation from the Food and Drug Administration in a letter releasedRead More
How Unproven Alzheimer’s Drug Approved?
[ad_1] The idea of expedited approval was proposed by the FDA’s oncology center chair and non-council member Dr. It was brought up by Rick Pazdur. It wasn’t discussed in detail,Read More
FDA Is Investigating Its Own Alzheimer’s Drug Approval
[ad_1] The Food and Drug Administration on Friday called for a federal investigation of the process that led to the approval of a new drug for Alzheimer’s disease, which hasRead More
In A Reversal, FDA Calls for Limits on Who Takes Alzheimer’s Drugs
[ad_1] Faced with harsh criticism for approving a controversial drug for all Alzheimer’s patients, the Food and Drug Administration has largely narrowed his recommendationsuggests that only those with mild memoryRead More
A New Alzheimer’s Drug Offers More Questions Than Answers
[ad_1] A geriatrician at the University of Nebraska Medical Center, Dr. “This puts us in a bad place,” Karina Bishop agreed. Ethically, he added, “if this drug were available now,Read More